Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24
Large-scale testing (Phase 3)Study completedNCT01467362
What this trial is testing

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pierre Fabre Medicament 251
Testing effectiveness (Phase 2)Study completedNCT04992546
What this trial is testing

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Principia Biopharma, a Sanofi Company 39
Testing effectiveness (Phase 2)Ended earlyNCT05911841
What this trial is testing

LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 234
Testing effectiveness (Phase 2)Study completedNCT01552629
What this trial is testing

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 22
Not applicableWithdrawnNCT05006300
What this trial is testing

Evaluation of the Efficacy of Topialyse Baume barrière on Atopic Dermatis

Who this might be right for
Atopic Dermatitis
SVR Group
Not applicableLooking for participantsNCT07014007
What this trial is testing

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 105
Post-approval studies (Phase 4)WithdrawnNCT03710044
What this trial is testing

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma
Not applicableStudy completedNCT00275795
What this trial is testing

NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®

Who this might be right for
Food SensitivitiesHeadacheBackache+2 more
Nambudripad's Allergy Research Foundation 42
Testing effectiveness (Phase 2)Study completedNCT00867607
What this trial is testing

Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis

Who this might be right for
Allergic Contact Dermatitis
Hadassah Medical Organization 13
Large-scale testing (Phase 3)Ended earlyNCT05387707
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Cara Therapeutics, Inc. 287
Not applicableStudy completedNCT06427122
What this trial is testing

Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

Who this might be right for
Atopic DermatitisPrurigo Nodularis
Tamar Nijsten 96
Testing effectiveness (Phase 2)Looking for participantsNCT07330934
What this trial is testing

Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 403
Large-scale testing (Phase 3)Study completedNCT03002571
What this trial is testing

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

Who this might be right for
Atopic Dermatitis
Bausch Health Americas, Inc. 338
Not applicableLooking for participantsNCT05391061
What this trial is testing

Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 1,100
Not applicableStudy completedNCT04728269
What this trial is testing

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
PiLeJe 10
Not applicableStudy completedNCT05057351
What this trial is testing

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Who this might be right for
Mild to Moderate Atopic Dermatitis
Greenpharma S.A.S. 44
Not applicableStudy completedNCT00550472
What this trial is testing

The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University of Jena 30
Large-scale testing (Phase 3)Looking for participantsNCT07542483
What this trial is testing

Lebrikizumab in Adults With Nummular Eczema

Who this might be right for
Nummular Eczema
Almirall, S.A. 270
Large-scale testing (Phase 3)Study completedNCT03989349
What this trial is testing

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 787
Next Page